BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12498984)

  • 21. The effect of 2,3-dihydroxybenzoic acid and tempol in prevention of vancomycin-induced nephrotoxicity in rats.
    Naghibi B; Ghafghazi T; Hajhashemi V; Talebi A; Taheri D
    Toxicology; 2007 Apr; 232(3):192-9. PubMed ID: 17296255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism in rat liver microsomes of the nitroxide spin probe tempol.
    Iannone A; Bini A; Swartz HM; Tomasi A; Vannini V
    Biochem Pharmacol; 1989 Aug; 38(16):2581-6. PubMed ID: 2764982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tempol, a superoxide dismutase-mimetic drug, prevents chronic ischemic renal injury in two-kidney, one-clip hypertensive rats.
    Nunes DV; Costa CA; De Bem GF; Cordeiro VS; Santos IB; Carvalho LC; Jordão AK; Cunha AC; Ferreira VF; Moura RS; Resende AC; Ognibene DT
    Clin Exp Hypertens; 2018; 40(8):721-729. PubMed ID: 29359965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides.
    Hahn SM; DeLuca AM; Coffin D; Krishna CM; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):839-42. PubMed ID: 9845107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of Tempol on ferritin synthesis and Fe metabolism in lens epithelial cells.
    Goralska M; Holley B; McGahan MC
    Biochim Biophys Acta; 2000 Jun; 1497(1):51-60. PubMed ID: 10838158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tempol, a stable free radical, is a novel murine radiation protector.
    Hahn SM; Tochner Z; Krishna CM; Glass J; Wilson L; Samuni A; Sprague M; Venzon D; Glatstein E; Mitchell JB
    Cancer Res; 1992 Apr; 52(7):1750-3. PubMed ID: 1551104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tempol, one of nitroxides, is a novel ultraviolet-A1 radiation protector for human dermal fibroblasts.
    Yan SX; Hong XY; Hu Y; Liao KH
    J Dermatol Sci; 2005 Mar; 37(3):137-43. PubMed ID: 15734282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioxidant properties of MitoTEMPOL and its hydroxylamine.
    Trnka J; Blaikie FH; Logan A; Smith RA; Murphy MP
    Free Radic Res; 2009 Jan; 43(1):4-12. PubMed ID: 19058062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitroxides as antioxidants.
    Krishna MC; Samuni A
    Methods Enzymol; 1994; 234():580-9. PubMed ID: 7808334
    [No Abstract]   [Full Text] [Related]  

  • 30. Oxidative stress causes imbalance of renal renin angiotensin system (RAS) components and hypertension in obese Zucker rats.
    Luo H; Wang X; Chen C; Wang J; Zou X; Li C; Xu Z; Yang X; Shi W; Zeng C
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25687731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo.
    Ritchie RH; Quinn JM; Cao AH; Drummond GR; Kaye DM; Favaloro JM; Proietto J; Delbridge LM
    J Mol Cell Cardiol; 2007 Jun; 42(6):1119-28. PubMed ID: 17490678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice.
    Kobayashi M; Sugiyama H; Wang DH; Toda N; Maeshima Y; Yamasaki Y; Masuoka N; Yamada M; Kira S; Makino H
    Kidney Int; 2005 Sep; 68(3):1018-31. PubMed ID: 16105032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidant Supplementation Modulates Age-Related Placental Bed Morphology and Reproductive Outcome in Mice.
    Silva E; Soares AI; Costa F; Castro JP; Matos L; Almeida H
    Biol Reprod; 2015 Sep; 93(3):56. PubMed ID: 26178715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural requirements for optimized delivery, inhibition of oxidative stress, and antiapoptotic activity of targeted nitroxides.
    Jiang J; Kurnikov I; Belikova NA; Xiao J; Zhao Q; Amoscato AA; Braslau R; Studer A; Fink MP; Greenberger JS; Wipf P; Kagan VE
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1050-60. PubMed ID: 17179468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tempol, a Superoxide Dismutase-Mimetic Drug, Ameliorates Progression of Renal Disease in CKD Mice.
    Ding W; Wang B; Zhang M; Gu Y
    Cell Physiol Biochem; 2015; 36(6):2170-82. PubMed ID: 26279424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats.
    Park JB; Touyz RM; Chen X; Schiffrin EL
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):78-84. PubMed ID: 11824865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hair Follicle Damage after 100 mGy Low-Dose Fractionated X-Ray Irradiation and the Protective Effects of TEMPOL, a Stable Nitroxide Radical, against Radiation.
    Kawabata Y; Fukushige T; Indo HP; Matsumoto KI; Ueno M; Nakanishi I; Chatatikun M; Klangbud WK; Surinkaew S; Tangpong J; Kanekura T; Majima HJ
    Radiat Res; 2024 Feb; 201(2):115-125. PubMed ID: 38211765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective Effect of Tempol on Buthionine Sulfoximine-Induced Mitochondrial Impairment in Hippocampal Derived HT22 Cells.
    Salvi A; Patki G; Khan E; Asghar M; Salim S
    Oxid Med Cell Longev; 2016; 2016():5059043. PubMed ID: 27069531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic effect of the nitroxide superoxide dismutase mimics.
    Hahn SM; Sullivan FJ; DeLuca AM; Bacher JD; Liebmann J; Krishna MC; Coffin D; Mitchell JB
    Free Radic Biol Med; 1999 Sep; 27(5-6):529-35. PubMed ID: 10490272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria.
    Trnka J; Blaikie FH; Smith RA; Murphy MP
    Free Radic Biol Med; 2008 Apr; 44(7):1406-19. PubMed ID: 18206669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.